Alimba, Darwin O.

HRN: 22-81-52  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CEFTRIAXONE 1G (VIAL)
04/01/2023
04/08/2023
IV
2gm
OD
Non-healing Wound
Waiting Final Action 
04/01/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/01/2023
04/08/2023
IV
600mg
Q8
Non-healing Wound
Waiting Final Action 
04/02/2023
CO-AMOXICLAV 625MG (TAB)
04/02/2023
04/09/2023
PO
625mg
TID
Non Healing Wound
Waiting Final Action 
04/02/2023
CLINDAMYCIN 300MG (CAP)
04/02/2023
04/09/2023
PO
300 Mg
Q6
Non Healing Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: